Drug development in Alzheimer’s disease: the path to 2025

The global impact of Alzheimer’s disease (AD) continues to increase, and focused efforts are needed to address this immense public health challenge. National leaders have set a goal to prevent or effectively treat AD by 2025. In this paper, we discuss the path to 2025, and what is feasible in this t...

Descripción completa

Detalles Bibliográficos
Autores principales: Cummings, Jeffrey, Aisen, Paul S., DuBois, Bruno, Frölich, Lutz, Jack, Clifford R., Jones, Roy W., Morris, John C., Raskin, Joel, Dowsett, Sherie A., Scheltens, Philip
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5028936/
https://www.ncbi.nlm.nih.gov/pubmed/27646601
http://dx.doi.org/10.1186/s13195-016-0207-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5028936/
https://www.ncbi.nlm.nih.gov/pubmed/27646601
http://dx.doi.org/10.1186/s13195-016-0207-9

Ejemplares similares